This IL-17-tumor cell signaling is necessary for the survival and outgrowth of early CRC lesions, and ablation of IL-17RA, the common receptor of IL-17 family cytokines, resulted in marked reduction in tumor numbers in mouse colon [1, 3]. This evidence concerns the gene IL17A and colorectal carcinoma.